383 related articles for article (PubMed ID: 3935096)
1. The effects of pantethine on lipid and lipoprotein abnormalities in survivors of cerebral infarction.
Murai A; Miyahara T; Tanaka T; Sako Y; Nishimura N; Kameyama M
Artery; 1985; 12(4):234-43. PubMed ID: 3935096
[TBL] [Abstract][Full Text] [Related]
2. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
Oida K; Nakai T; Tamai T; Kutsumi Y; Kobayashi T; Hayashi T; Yamada S; Takeda R
Artery; 1982; 10(4):266-85. PubMed ID: 7181672
[TBL] [Abstract][Full Text] [Related]
3. Changes in plasma lipids, lipoproteins and apolipoproteins in hypercholesterolaemic patients treated with pravastatin.
Lijnen P; Celis H; Desager JP; Fagard R
J Hum Hypertens; 1995 Jul; 9(7):557-64. PubMed ID: 7562885
[TBL] [Abstract][Full Text] [Related]
4. [Effect of pantethine on the lipoprotein abnormalities in survivors of cerebral infarction (author's transl)].
Murai A; Miyahara T; Tanaka T; Sako Y; Kameyama M; Nishimura N
Nihon Ronen Igakkai Zasshi; 1980 Nov; 17(6):624-9. PubMed ID: 7206301
[No Abstract] [Full Text] [Related]
5. Acute influence of smoking on plasma lipoproteins.
Gnasso A; Haberbosch W; Schettler G; Schmitz G; Augustin J
Klin Wochenschr; 1984; 62 Suppl 2():36-42. PubMed ID: 6482326
[TBL] [Abstract][Full Text] [Related]
6. Lipoprotein changes in children after liver transplantation: mild hypertriglyceridemia and a decrease in HDL3/HDL2 ratio.
Granot E
Hepatology; 1998 Jan; 27(1):175-80. PubMed ID: 9425934
[TBL] [Abstract][Full Text] [Related]
7. Characterization of plasma lipoproteins in survivors of cerebral infarction.
Murai A; Miyahara T; Tanaka T; Kameyama M
Tohoku J Exp Med; 1986 Jan; 148(1):57-64. PubMed ID: 3705064
[TBL] [Abstract][Full Text] [Related]
8. [Value of the analysis of lipoproteins after myocardial infarction].
Dewailly P; Mellin D; Moulin S; Rouget JP; Sezille G; Jaillard J
Presse Med; 1983 Jul 9-16; 12(29):1807-10. PubMed ID: 6224195
[TBL] [Abstract][Full Text] [Related]
9. Lipoprotein changes induced by pantethine in hyperlipoproteinemic patients: adults and children.
Bertolini S; Donati C; Elicio N; Daga A; Cuzzolaro S; Marcenaro A; Saturnino M; Balestreri R
Int J Clin Pharmacol Ther Toxicol; 1986 Nov; 24(11):630-7. PubMed ID: 3098691
[TBL] [Abstract][Full Text] [Related]
10. Influence of cholesterol-lowering on plasma membrane lipids and function.
Lijnen P; Echevaría-Vázquez D; Petrov V
Methods Find Exp Clin Pharmacol; 1996 Mar; 18(2):123-36. PubMed ID: 8740244
[TBL] [Abstract][Full Text] [Related]
11. Decrease of plasma large, light LDL (LDL1), HDL2 and HDL3 levels with concomitant increase of cholesteryl ester transfer protein (CETP) activity by probucol in type II hyperlipoproteinemia.
Homma Y; Kobayashi T; Yamaguchi H; Sakane H; Ozawa H; Matsuda M; Mikami Y; Mikami Y; Nakamura H
Artery; 1993; 20(1):1-18. PubMed ID: 8447724
[TBL] [Abstract][Full Text] [Related]
12. Improved lipoprotein surface and core lipid composition following intraperitoneal insulin delivery in insulin-dependent diabetes mellitus.
Bagdade JD; Dunn FL
Diabetes Metab; 1996 Dec; 22(6):420-6. PubMed ID: 8985650
[TBL] [Abstract][Full Text] [Related]
13. [Concentration of lipids and apolipoproteins A-I, A-II and E in blood plasma of men with chronic alcoholism].
Triufanov VF; Usatenko MS; Bokiĭ IV
Vopr Med Khim; 1981; 27(3):397-402. PubMed ID: 6792781
[TBL] [Abstract][Full Text] [Related]
14. [Disruption of the cholesterol-transport function of lipoproteins in the blood plasma of patients with ischemic heart disease].
Gerasimova EN; Perova NV; Kurdanov KhA; Polesskiĭ VA
Vopr Med Khim; 1984; 30(6):71-6. PubMed ID: 6528538
[TBL] [Abstract][Full Text] [Related]
15. [Atherosclerosis in familial hypercholesteremia possibly induced by defective HDL].
Breier C; Lisch HJ; Drexel H; Braunsteiner H
Schweiz Med Wochenschr; 1984 Mar; 114(9):288-91. PubMed ID: 6710113
[TBL] [Abstract][Full Text] [Related]
16. [Serum lipids and lipoproteins in patients with cerebrovascular disorders].
Lorenc J; Kościuk N
Przegl Lek; 1989; 46(9):681-5. PubMed ID: 2595002
[TBL] [Abstract][Full Text] [Related]
17. Serum lipoprotein lipids after gemfibrozil treatment.
Schwandt P; Weisweiler P; Neureuther G
Artery; 1979 Feb; 5(2):117-24. PubMed ID: 231950
[TBL] [Abstract][Full Text] [Related]
18. Effect of metabolic control of the serum lipid and lipoprotein levels on insulin-dependent diabetes mellitus.
Romics L; Karádi I; Rozenberczki M; Kammerer L
Acta Med Acad Sci Hung; 1982; 39(3-4):117-23. PubMed ID: 6764327
[TBL] [Abstract][Full Text] [Related]
19. Effects of short-term modest weight loss on fasting and post-prandial lipoprotein sub-fractions in type 2 diabetes mellitus patients.
Ybarra J; James RW; Makoundou V; Bioletto S; Golay A
Diabetes Metab; 2001 Dec; 27(6):701-8. PubMed ID: 11852380
[TBL] [Abstract][Full Text] [Related]
20. Serum lipoproteins and apolipoproteins A I and A II in male patients with peripheral arterial insufficiency.
Angquist KA; Johnson O; Ericsson M; Tollin C
Acta Chir Scand; 1982; 148(8):675-8. PubMed ID: 6820598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
